EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access

Fentanyl Test Strip Use and Overdose Risk Reduction Behaviors Among People Who Use Drugs

Rachel A Vickers-Smith, Kitty H Gelberg, Janet E Childerhose, Denise C Babineau, Redonna Chandler, James L David, Lauren D'Costa, Megan Dzurec, Barry Eggleston, Amanda Fallin-Bennett, Laura C Fanucchi, Soledad Fernandez und 21 weitere

JAMA Network Open · 2025

DOI: 10.1001/jamanetworkopen.2025.10077 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift JAMA Network Open, 2025. Verfasst von Rachel A Vickers-Smith und 32 weiteren Autor:innen. Beteiligte Einrichtung: College of Public Health, University of Kentucky, Lexington. Hauptthemen laut MEDLINE: Fentanyl, Drug Overdose, Risk Reduction Behavior, Substance Abuse Detection. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Illegal fentanyl is driving overdose mortality, and fentanyl test strips (FTS) can be used to test drugs for fentanyl at the point of consumption. Evidence on whether FTS use is associated with overdose risk reduction behaviors is encouraging, but largely limited to smaller, single-site studies.

Objective

To determine whether self-reported baseline FTS use among people who use drugs (PWUD) was associated with overdose risk reduction behaviors and nonfatal overdose over a 28-day follow-up. Design, Setting, and Participants Multisite, observational cohort study of PWUD conducted from May to December 2023 as an ancillary study of the HEALing Communities Study, which consists of fixed and mobile direct service provision sites in 14 community partner organizations distributing FTS. Participants lived in Kentucky, New York, or Ohio and reported using heroin, fentanyl, cocaine, methamphetamine, or nonprescribed opioids, benzodiazepines, or stimulants within 30 days before baseline. Participants were followed up for a maximum of 37 days. Exposure Baseline FTS use. Main Outcome and Measures The primary outcome was a composite score measuring the self-reported number and frequency of using 8 overdose risk reduction behaviors. Secondary outcomes included multiple measures (eg, self-reported nonfatal overdose).

Results

The study included 732 participants (median [IQR] age, 41 [34.0-48.0] years; 369 [50.4%] male; 64 [8.9%] Black or African American, 587 [81.3%] White, and 71 [9.8%] other races); 414 reported baseline FTS use and 318 did not. Compared with nonusers, a higher percentage of baseline FTS users were from Ohio and White, while a lower percentage were from New York and Hispanic and/or Black. In adjusted analyses, PWUD who used FTS had a mean daily composite score for overdose risk reduction behaviors that was 0.86 (95% CI, 0.34-1.38) units higher across follow-up compared with nonusers (score for FTS users, 7.37; nonusers, 6.51). There was no difference in self-reported nonfatal overdoses between the 2 groups (mean daily risk for FTS users, 0.02; nonusers, 0.02; risk ratio, 1.20; 95% CI, 0.70-2.06). Conclusions and Relevance In this cohort study, baseline FTS use was associated with greater engagement in overdose risk reduction behaviors during follow-up, but not with the risk of nonfatal overdose during follow-up, suggesting PWUD who use FTS may also engage in a broader set of harm reduction strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FentanylDrug OverdoseRisk Reduction BehaviorSubstance Abuse DetectionDrug UsersHumansMaleFemaleAdultMiddle AgedCohort StudiesSelf ReportAnalgesics, OpioidKentuckyOhioNew York

Substanzen

FentanylAnalgesics, Opioid

Autor:innen und Institutionen

  • College of Public Health, University of Kentucky, Lexington.
  • School of Social Work, Columbia University, New York, New York.
  • Division of Internal Medicine, The Ohio State University College of Medicine, Columbus.
  • Research Triangle Institute International, Research Triangle Park, North Carolina.
  • National Institute on Drug Abuse, Bethesda, Maryland.
  • The Ohio State University College of Medicine, Columbus.

Förderung

  • NIDA NIH HHS

Zitieren

APA

Vickers-Smith, R. A., Gelberg, K. H., Childerhose, J. E., Babineau, D. C., Chandler, R., David, J. L., D'Costa, L., Dzurec, M., Eggleston, B., Fallin-Bennett, A., Fanucchi, L. C., Fernandez, S., Gilbert, J., Gilbert, L., Hall, M. E., Hiltz, B. E., Konstan, M. W., Lancaster, K. E., Linas, B., …, & Freisthler, B. (2025). Fentanyl Test Strip Use and Overdose Risk Reduction Behaviors Among People Who Use Drugs. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.10077

Vancouver

Vickers-Smith RA, Gelberg KH, Childerhose JE, Babineau DC, Chandler R, David JL, et al. Fentanyl Test Strip Use and Overdose Risk Reduction Behaviors Among People Who Use Drugs. JAMA Network Open. 2025. doi:10.1001/jamanetworkopen.2025.10077

BibTeX
@article{VickersSmith2025,
  author = {Vickers-Smith, Rachel A and Gelberg, Kitty H and Childerhose, Janet E and Babineau, Denise C and Chandler, Redonna and David, James L and D'Costa, Lauren and Dzurec, Megan and Eggleston, Barry and Fallin-Bennett, Amanda and Fanucchi, Laura C and Fernandez, Soledad and Gilbert, Jace and Gilbert, Louisa and Hall, Megan E and Hiltz, Brooke E and Konstan, Michael W and Lancaster, Kathryn E and Linas, Beth and Marks, Katherine R and Michaels, Nichole and Miles, Jennifer and Montero, Fernando and Ramsey Harden, Haley J and Roeber, Carter and Russo, Mary R and Taylor, Rachel and Theis, Melissa A and Villani, Jennifer and Oga, Emmanuel and El-Bassel, Nabila and Walsh, Sharon L and Freisthler, Bridget},
  title = {Fentanyl Test Strip Use and Overdose Risk Reduction Behaviors Among People Who Use Drugs},
  journal = {JAMA Network Open},
  year = {2025},
  doi = {10.1001/jamanetworkopen.2025.10077}
}
Kostenlos starten →